SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
about
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
@en
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
@nl
type
label
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
@en
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
@nl
prefLabel
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
@en
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
@en
P2093
Fengqi Liu
Haihe Wang
Hehua Wang
Mingming Zhang
Shulan Yang
P2860
P356
10.1080/10428194.2017.1344843
P577
2017-07-06T00:00:00Z